The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Monoamine neurocircuitry in depression and strategies for new treatments
Abstract
Extensive studies showed that monoaminergic neurotransmission that involves serotonin (5-HT), norepinephrine (NE) and dopamine (DA) exerts major influence on brain circuits concerned by the regulation of mood, reactivity to psychological stress, self-control, motivation, drive, and cognitive performance. Antidepressants targeting monoamines directly affect the functional tone of these circuits, notably in limbic and frontocortical areas, and evidence has been provided that this action plays a key role in their therapeutic efficacy. Indeed, at least some of functional changes detected by functional magnetic resonance imaging in emotion- and cognitive-related circuits such as the one involving limbic-cortical-striatal-pallidal-thalamic connections in depressed patients can be reversed by monoamine-targeted antidepressants. However, antidepressants acting selectively on only one monoamine, such as selective inhibitors of 5-HT or NE reuptake, alleviate depression symptoms in a limited percentage of patients, and are poorly effective to prevent recurrence. Thorough investigations for the last 30 years allowed the demonstration of the existence of functional interactions between 5-HT, NE and DA systems, and the identification of the specific receptors involved. In particular, 5-HT systems were shown to exert negative influence on NE and DA systems through 5-HT2A and 5-HT2C receptor- mediated mechanisms, respectively. On the other hand, complex positive and negative influences of NE…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current theories for SSRI- mediated treatment of depression include increased production of BDNF (22), increased hippocampal neurogenesis (23–25) and reduced expression of serotonin autoreceptors (26).”
From An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice (2014) · cites this paper as [26]
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Research works printed but not linked: 94
- Albert, 2010, Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy, Front Neurosci, 4, 1
- Albert, 2011, Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness, Mol Brain, 4, 21, 10.1186/1756-6606-4-21 · DOI
- Anisman, 2008, Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects, J Psychiatry Neurosci, 33, 131
- Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biol Psychiatry, 47, 351, 10.1016/S0006-3223(99)00230-9 · DOI · Paper page
- Bhagwagar, 2004, Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635, Mol Psychiatry, 9, 386, 10.1038/sj.mp.4001401 · DOI · Paper page
- Blier, 1983, Electrophysiological investigations on the effect of zimelidine administration on serotonergic neurotransmission in the rat, J Neurosci, 3, 1270, 10.1523/JNEUROSCI.03-06-01270.1983 · DOI · Paper page
- Blier, 2003, Is there a role for 5-HT1A agonists in the treatment of depression?, Biol Psychiatry, 53, 193, 10.1016/S0006-3223(02)01643-8 · DOI · Paper page
- Blier, 2009, Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation, Eur Neuropsychopharmacol, 19, 457, 10.1016/j.euroneuro.2009.01.015 · DOI · Paper page
- Boldrini, 2008, Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides, J Psychiatr Res, 42, 433, 10.1016/j.jpsychires.2007.05.004 · DOI · Paper page
- Bonnavion, 2010, Heterogeneous distribution of the serotonin 5-HT1A receptor mRNA in chemically identified neurons of the mouse rostral brainstem: implications for the role of serotonin in the regulation of wakefulness and REM sleep, J Comp Neurol, 518, 2744, 10.1002/cne.22331 · DOI
- Boothman, 2006, In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism, Br J Pharmacol, 149, 861, 10.1038/sj.bjp.0706935 · DOI
- Bortolozzi, 2012, New antidepressant strategy based on acute siRNA silencing of 5-HT1A autoreceptors, Mol Psychiatry, 17, 567, 10.1038/mp.2012.52 · DOI
- Brodaty, 1993, Prognosis of depression in the elderly. A comparison with younger patients, Br J Psychiatry, 163, 589, 10.1192/bjp.163.5.589 · DOI
- Campbell, 2004, Lower hippocampal volume in patients suffering from depression: a meta-analysis, Am J Psychiatry, 161, 598, 10.1176/appi.ajp.161.4.598 · DOI · Paper page
- Cassel, 2006, Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain, Mol Pharmacol, 70, 487, 10.1124/mol.106.022301 · DOI · Paper page
- Coupland, 2005, Decreased prefrontal myo-inositol in major depressive disorder, Biol Psychiatry, 57, 1526, 10.1016/j.biopsych.2005.02.027 · DOI · Paper page
- Debonnel, 2007, Differential physiological effects of a low dose and high doses of venlafaxine in major depression, Int J Neuropsychopharmacol, 10, 51, 10.1017/S1461145705006413 · DOI
- De Deurwaerdère, 2004, Constitutive activity of the serotonin 2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens, J Neurosci, 24, 3235, 10.1523/JNEUROSCI.0112-04.2004 · DOI · Paper page
- Delgado, 1999, Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action, Biol Psychiatry, 46, 212, 10.1016/S0006-3223(99)00014-1 · DOI · Paper page
- Delgado, 2006, Depression: the case for a monoamine deficiency, J Clin Psychiatry, 61, 7
- Diazgranados, 2010, A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression, Arch Gen Psychiatry, 67, 793, 10.1001/archgenpsychiatry.2010.90 · DOI · Paper page
- Dremencov, 2009, Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area, J Psychiatry Neurosci, 34, 223
- Dremencov, 2007, Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain, Biol Psychiatry, 61, 671, 10.1016/j.biopsych.2006.05.015 · DOI
- Dziedzicka-Wasylewska, 2006, Effect of antidepressant drugs in mice lacking the norepinephrine transporter, Neuropsychopharmacology, 31, 2424, 10.1038/sj.npp.1301064 · DOI
- Fabre, 2000, Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter, Eur J Neurosci, 12, 2299, 10.1046/j.1460-9568.2000.00126.x · DOI · Paper page
- Guiard, 2011, Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons, Int J Neuropsychopharmacol, 14, 211, 10.1017/S1461145710000076 · DOI
- Guo, 2011, Abnormal neural activities in first-episode, treatment-naïve, short-illness-duration, and treatment-response patients with major depressive disorder: a resting-state fMRI study, J Affect Disord, 135, 326, 10.1016/j.jad.2011.06.048 · DOI
- Hammar, 2010, Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm, Scand J Psychol, 51, 304
- Hamon, 2006, Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects?, Eur Neuropsychopharmacol, 16, S625, 10.1016/S0924-977X(06)70008-6 · DOI
- Holtzheimer, 2011, Deep brain stimulation for psychiatric disorders, Annu Rev Neurosci, 34, 289, 10.1146/annurev-neuro-061010-113638 · DOI · Paper page
- Jacobsen, 2012, Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice, Mol Psychiatry, 17, 694, 10.1038/mp.2011.50 · DOI
- Judd, 2000, Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?, Am J Psychiatry, 157, 1501, 10.1176/appi.ajp.157.9.1501 · DOI · Paper page
- Karg, 2011, The serotonin transporter promoter variant(5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation, Arch Gen Psychiatry, 68, 444, 10.1001/archgenpsychiatry.2010.189 · DOI · Paper page
- Kasper, 2009, Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action, World J Biol Psychiatry, 10, 117, 10.1080/15622970902717024 · DOI
- Kennedy, 2001, Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression, Am J Psychiatry, 158, 899, 10.1176/appi.ajp.158.6.899 · DOI · Paper page
- Kitaichi, 2010, Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats, Eur J Pharmacol, 647, 90, 10.1016/j.ejphar.2010.08.026 · DOI
- Koch, 2003, Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats, Neuropharmacology, 45, 935, 10.1016/S0028-3908(03)00268-5 · DOI
- Kondo, 2005, Differential connections of the perirhinal and parahippocampal cortex with the orbital and medial prefrontal networks in macaque monkeys, J Comp Neurol, 493, 479, 10.1002/cne.20796 · DOI · Paper page
- Lanfumey, 2004, 5-HT1 receptors, Curr Drug Targets - CNS Neurol Disord, 3, 1, 10.2174/1568007043482570 · DOI · Paper page
- Lanfumey, 2008, Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders, Neurosci Biobehav Rev, 32, 1174, 10.1016/j.neubiorev.2008.04.006 · DOI · Paper page
- Lesch, 1996, Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region, Science, 274, 1527, 10.1126/science.274.5292.1527 · DOI · Paper page
- Li, 2010, mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science, 329, 959, 10.1126/science.1190287 · DOI · Paper page
- Lira, 2003, Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice, Biol Psychiatry, 54, 960, 10.1016/S0006-3223(03)00696-6 · DOI · Paper page
- Lisiecka, 2011, Neural correlates of treatment outcome in major depression, Int J Neuropsychopharmacol, 14, 521, 10.1017/S1461145710001513 · DOI
- Maciag, 2010, Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies, Biol Psychiatry, 67, 465, 10.1016/j.biopsych.2009.10.027 · DOI · Paper page
- Massart, 2012, Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression, Philos Trans R Soc Lond B Biol Sci, 367, 2485, 10.1098/rstb.2012.0212 · DOI · Paper page
- McKinnon, 2009, A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder, J Psychiatry Neurosci, 34, 41
- Millet, 2010, Psychiatric indications of deep brain stimulation, Bull Acad Natl Med, 194, 583
- Milner, 1998, Hippocampal alpha2a-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes, J Comp Neurol, 395, 310, 10.1002/(SICI)1096-9861(19980808)395:3<310::AID-CNE4>3.0.CO;2-5 · DOI
- Mongeau, 2010, 5–HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation Modulation by chronic paroxetine treatment, J Neurochem, 115, 438, 10.1111/j.1471-4159.2010.06932.x · DOI
- Mnie-Filali, 2011, Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy, Neuropsychopharmacology, 36, 1275, 10.1038/npp.2011.13 · DOI
- Montgomery, 1994, Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates, Int Clin Psychopharmacol, 9, 47, 10.1097/00004850-199400910-00008 · DOI · Paper page
- Oades, 1987, Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity, Brain Res, 434, 117, 10.1016/0165-0173(87)90011-7 · DOI · Paper page
- Ordway, 2003, Elevated agonist binding to alpha 2-adrenoceptors in the locus coeruleus in major depression, Biol Psychiatry, 53, 315, 10.1016/S0006-3223(02)01728-6 · DOI
- Owen, 2011, Vilazodone: a new treatment option for major depressive disorder, Drugs Today (Barc), 47, 531, 10.1358/dot.2011.47.7.1622076 · doi:10.1358/dot.2011.47.7.1622076
- Owens, 2001, Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine, Biol Psychiatry, 50, 345, 10.1016/S0006-3223(01)01145-3 · DOI · Paper page
- Page, 2002, Behavioral and neurochemical effects of 5-{4-[4-(5-cyano-3indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine 1A receptor partial agonist, J Pharmacol Exp Ther, 302, 1220, 10.1124/jpet.102.034280 · DOI
- Paizanis, 2007, Life-long hippocampal neurogenesis: environmental, pharmacological and neurochemical modulations, Neurochem Res, 32, 1762, 10.1007/s11064-007-9330-0 · DOI
- Pandey, 2002, Higher expression of serotonin 5-HT2A receptors in the postmortem brains of teenage suicide victims, Am J Psychiatry, 159, 419, 10.1176/appi.ajp.159.3.419 · DOI · Paper page
- Parsey, 2006, Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study, Neuropsychopharmacology, 31, 1745, 10.1038/sj.npp.1300992 · DOI · Paper page
- Parsey, 2006, Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study, Biol Psychiatry, 59, 106, 10.1016/j.biopsych.2005.06.016 · DOI · Paper page
- Pehrson, 2012, Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters – a rat microdialysis and electrophysiological study, Eur Neuropsychopharmacol, 23, 133, 10.1016/j.euroneuro.2012.04.006 · DOI · Paper page
- Piñeyro, 1999, Autoregulation of serotonin neurons: role in antidepressant drug action, Pharmacol Rev, 51, 533
- Pitchot, 2005, 5-Hydroxytryptamine 1A receptor, major depression, and suicidal behavior, Biol Psychiatry, 58, 854, 10.1016/j.biopsych.2005.05.042 · DOI
- Pitchot, 2004, Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study, Eur Neuropsychopharmacol, 14, 151, 10.1016/S0924-977X(03)00108-1 · DOI
- Portella, 2011, Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression, J Clin Psychiatry, 72, 962, 10.4088/JCP.09m05827blu · DOI
- Price, 2012, Neural circuits underlying the pathophysiology of mood disorders, Trends Cogn Sci, 16, 61, 10.1016/j.tics.2011.12.011 · DOI · Paper page
- Riad, 2000, Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain, J Comp Neurol, 417, 181, 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A · DOI · Paper page
- Richardson-Jones, 2010, 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants, Neuron, 65, 40, 10.1016/j.neuron.2009.12.003 · DOI · Paper page
- Richelson, 2010, New antipsychotic drugs: how do their receptor-binding profiles compare?, J Clin Psychiatry, 71, 1243, 10.4088/JCP.10ac06470yel · DOI
- Rosel, 2000, Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims, Psychiatry Res, 99, 173, 10.1016/S0925-4927(00)00076-7 · DOI
- Rush, 2011, Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study, Am J Psychiatry, 168, 689, 10.1176/appi.ajp.2011.10111645 · DOI · Paper page
- Saleem, 2008, Complementary circuits connecting the orbital and medial prefrontal networks with the temporal, insular, and opercular cortex in the macaque monkey, J Comp Neurol, 506, 659, 10.1002/cne.21577 · DOI · Paper page
- Sánchez, 1999, Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding, Cell Mol Neurobiol, 19, 467, 10.1023/A:1006986824213 · DOI · Paper page
- Sari, 1999, Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies, Neuroscience, 88, 899, 10.1016/S0306-4522(98)00256-5 · DOI · Paper page
- Schramm, 2001, The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety, J Neurosci, 21, 4875, 10.1523/JNEUROSCI.21-13-04875.2001 · DOI · Paper page
- Scorza, 2011, Preclinical and clinical characterization of the selective serotonin-1A receptor antagonist DU-125530 for antidepressant treatment, Br J Pharmacol, 167, 1021, 10.1111/j.1476-5381.2011.01770.x · DOI · Paper page
- Seletti, 1995, Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses, Neuropsychopharmacology, 13, 93, 10.1016/0893-133X(95)00025-9 · DOI
- Seminowicz, 2004, Limbic-frontal circuitry in major depression: a path modeling metanalysis, Neuroimage, 22, 409, 10.1016/j.neuroimage.2004.01.015 · DOI · Paper page
- Shopsin, 1975, Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients, Psychopharmacol Commun, 1, 239
- Shopsin, 1976, Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients, Arch Gen Psychiatry, 33, 811, 10.1001/archpsyc.1976.01770070041003 · DOI · Paper page
- Shimon, 1997, Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder, Am J Psychiatry, 154, 1148, 10.1176/ajp.154.8.1148 · DOI
- Stockmeier, 1998, Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression - postmortem evidence for decreased serotonin activity, J Neurosci, 18, 7394, 10.1523/JNEUROSCI.18-18-07394.1998 · DOI · Paper page
- Svenningsson, 2006, Alterations in 5-HT1B receptor function by p11 in depression-like states, Science, 311, 77, 10.1126/science.1117571 · DOI · Paper page
- Szabo, 2002, Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5–HT2A receptor antagonism on the firing activity of norepinephrine neurons, J Pharmacol Exp Ther, 302, 983, 10.1124/jpet.102.033282 · DOI
- Trivedi, 2008, Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression, J Clin Psychiatry, 69, 246, 10.4088/JCP.v69n0211 · DOI · Paper page
- Turcotte, 2001, Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects, Neuropsychopharmacology, 24, 511, 10.1016/S0893-133X(00)00220-7 · DOI
- Turecki, 1999, Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide, Am J Psychiatry, 156, 1456, 10.1176/ajp.156.9.1456 · DOI · Paper page
- Vincent, 2004, Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles, Circulation, 109, 3202, 10.1161/01.CIR.0000130847.18666.39 · DOI · Paper page
- Weaver, 2004, Epigenetic programming by maternal behavior, Nat Neurosci, 7, 847, 10.1038/nn1276 · DOI · Paper page
- Westrich, 2012, In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets, Int J Psychiatry Clin Pract, 16, 47
- Zhang, 2005, Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression, Neuron, 45, 11, 10.1016/j.neuron.2004.12.014 · DOI · Paper page
- Zhu, 2011, Altered white matter integrity in first-episode, treatment-naïve young adults with major depressive disorder: a tract-based spatial statistics study, Brain Res, 1369, 223, 10.1016/j.brainres.2010.10.104 · DOI · Paper page
- Zhuang, 1999, Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors, Neuropsychopharmacology, 21, 52S, 10.1016/S0893-133X(99)00047-0 · DOI · Paper page
Cited by
The role of sleep in emotional brain function
Goldstein, A. N., & Walker, M. P. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153716 · Cited by 1,052
“…the greater duration and/or intensity of REM sleep often reported in major depression may provide a mechanistic explanation for the abnormally low levels of noradrenaline commonly observed with this condition (Blier & Briley 2011, El Mansari et al 2010, Hamon & Blier 2013, Ordway et al 2003).”
BackgroundInfluentialLiang, S., Wang, T., Hu, X., Luo, J., Li, W., Wu, X., Duan, Y., & Jin, F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.033 · Cited by 651
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
The role of 5-HT receptors in depression
Yohn, C. N., Gergues, M. M., & Samuels, B. A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0306-y · Cited by 485
Tafet, G. E., & Nemeroff, C. B. (2016) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.15030053 · Cited by 393
Metadata
- Authors
- Hamon, M., & Blier, P.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 45
- Pages
- 54-63
- ISSN
- 0278-5846
- Cited by
- 594
- References
- 37
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monoamine neurocircuitry in depression and strategies for new treatments. https://app.cochat.ai/papers/10.1016/j.pnpbp.2013.04.009
- The paper
- Hamon, M., & Blier, P. (2013). Monoamine neurocircuitry in depression and strategies for new treatments. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/j.pnpbp.2013.04.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.